Paul Licciardi
Professor
Infection and Immunity
Murdoch Childrens Research Institute
Australia
Biography
Dr Paul Licciardi is a Research Fellow who leads the Vaccine Immunology Stream within the Pneumococcal Research Group. He completed his PhD in the Department of Pathology, University of Melbourne in 2008 where he then joined MCRI to complete his post-doc under the supervision of Professor Kim Mulholland. Paul's research interests include understanding the immunogenicity and long-term protection following alternative vaccination schedules in resource-limited settings, with a particular focus on pneumococcal and HPV vaccines. His research also spans immunological studies on RSV as well as the role of vitamin D and probiotics on human health. He is an investigator on a number of national and international grants from NHMRC, Gates Foundation, MRC-UK, AusAID and NIH, has presented at numerous scientific meetings and published more than 50 manuscripts and book chapters. As stream leader, Paul currently supervises a group of 14 staff and students, including two post-doctoral researchers, three PhD students, four Honours students, two research assistants and four international placement students.
Research Interest
Vaccine Immunology and malnutrition
Publications
-
Ismail IH, Boyle RJ, Licciardi PV, Oppedisano F, Lahtinen S, Robinsâ€Browne RM, Tang ML. Early gut colonization by Bifidobacterium breve and B. catenulatum differentially modulates eczema risk in children at high risk of developing allergic disease. Pediatric Allergy and Immunology. 2016 Dec 1;27(8):838-46.
-
Hoe E, Nathanielsz J, Toh ZQ, Spry L, Marimla R, Balloch A, Mulholland K, Licciardi PV. Anti-inflammatory effects of vitamin D on human immune cells in the context of bacterial infection. Nutrients. 2016 Dec 12;8(12):806.
-
Toh ZQ, Russell FM, Reyburn R, Fong J, Tuivaga E, Ratu T, Nguyen CD, Devi R, Kama M, Matanitobua S, Tabrizi SN. Sustained antibody responses six years following one two or three doses of quadrivalent HPV vaccine in adolescent Fijian girls and subsequent responses to a single dose of bivalent HPV vaccine: a prospective cohort study. Clinical infectious diseases. 2016.
